Fundraising Fox

SynGen

Sacramento, US · Founded 2012 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SynGen was founded in 2012 by George Barry and Philip H. Coelho.

GB
George BarryCo-Founder of Issuer
PH
Philip H. CoelhoChief Technology Officer and Co-Founder of Issuer
CN
Chuck NovakVice President and Chief Financial Officer of the Issuer
WG
William GerberChief Executive Officer and President of Issuer

Board

CGCarl Goldfischer
Carl GoldfischerBoard directorAdvisor, MD at Bay City Capital
WA
Woodrow A. Myers, Jr.Board director
VS
Vic SchmittBoard director

Investors · 1

Bay City CapitalSan Rafael · $5M – $10Mvia Carl Goldfischer · board

Reported raises · per SEC filings

Form D private placements

$12.2M disclosed across 11 of 12 rounds · 2013–2017

▶$400KraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Vic SchmittDirector
  • Philip H. CoelhoExecutive Officer
  • Chuck NovakExecutive Officer
  • George BarryDirector
  • Carl GoldfischerDirector
  • William GerberExecutive Officer, Director
  • Woodrow A. Myers, Jr.Director
Offering amount
$400K
Amount sold
$400K
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William GerberExecutive Officer, Director
  • George BarryDirector
  • Philip H. CoelhoExecutive Officer
  • Woodrow A. Myers, Jr.Director
  • Carl GoldfischerDirector
  • Chuck NovakExecutive Officer
  • Vic SchmittDirector
Offering amount
$500K
Amount sold
$500K
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Woodrow A. Myers, Jr.Director
  • Philip H. CoelhoExecutive Officer
  • Carl GoldfischerDirector
  • Chuck NovakExecutive Officer
  • William GerberExecutive Officer, Director
  • Vic SchmittDirector
  • George BarryDirector
Offering amount
$500K
Amount sold
$500K
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedFeb 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck NovakExecutive Officer
  • William GerberExecutive Officer, Director
  • Woodrow A. Myers, Jr.Director
  • Carl GoldfischerDirector
  • Vic SchmittDirector
  • George BarryDirector
  • Philip H. CoelhoExecutive Officer
Offering amount
$500K
Amount sold
$500K
First sale
Feb 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJan 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Woodrow A. Myers, Jr.Director
  • William GerberExecutive Officer, Director
  • Philip H. CoelhoExecutive Officer
  • George BarryDirector
  • Carl GoldfischerDirector
  • Vic SchmittDirector
  • Chuck NovakExecutive Officer
Offering amount
$500K
Amount sold
$500K
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedNov 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip H. CoelhoExecutive Officer
  • Carl GoldfischerDirector
  • George BarryDirector
  • Vic SchmittDirector
  • Chuck NovakExecutive Officer
  • William GerberExecutive Officer, Director
  • Woodrow A. Myers, Jr.Director
Offering amount
$1M
Amount sold
$1M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl GoldfischerDirector
  • Vic SchmittDirector
  • Chuck NovakExecutive Officer
  • Philip H. CoelhoExecutive Officer
  • George BarryDirector
  • William GerberExecutive Officer, Director
  • Woodrow A. Myers, Jr.Director
Offering amount
$2M
Amount sold
$1M
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedMay 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck NovakExecutive Officer
  • George BarryDirector
  • Vic SchmittDirector
  • Carl GoldfischerDirector
  • William GerberExecutive Officer, Director
  • Woodrow A. Myers, Jr.Director
  • Philip H. CoelhoExecutive Officer
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded SynGen?
SynGen was founded by George Barry, Philip H. Coelho in 2012.
Who are SynGen's investors?
SynGen's investors include Bay City Capital.
How much funding has SynGen raised?
SynGen has disclosed $12.2M raised across 11 of its 12 known rounds.
Where is SynGen headquartered?
SynGen is headquartered in Sacramento, US.